合煦智远金融科技指数(LOF)A
Search documents
用友网络股价跌5.05%,合煦智远基金旗下1只基金重仓,持有17.03万股浮亏损失13.96万元
Xin Lang Cai Jing· 2025-09-02 07:04
9月2日,用友网络跌5.05%,截至发稿,报15.42元/股,成交12.40亿元,换手率2.30%,总市值526.90亿 元。 从基金十大重仓股角度 风险提示:市场有风险,投资需谨慎。本文为AI大模型自动发布,任何在本文出现的信息(包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等)均只作为参考,不构成个人投资建 议。 数据显示,合煦智远基金旗下1只基金重仓用友网络。合煦智远金融科技指数(LOF)A(168701)二季度 减持3.1万股,持有股数17.03万股,占基金净值比例为2.14%,位居第九大重仓股。根据测算,今日浮 亏损失约13.96万元。 责任编辑:小浪快报 合煦智远金融科技指数(LOF)A(168701)成立日期2020年4月3日,最新规模5780.73万。今年以来收益 29.7%,同类排名1430/4222;近一年收益99.22%,同类排名275/3781;成立以来收益38.16%。 合煦智远金融科技指数(LOF)A(168701)基金经理为杨志勇。 资料显示,用友网络科技股份有限公司位于北京市海淀区北清路68号,香港铜锣湾勿地臣街1号时代广场 2座31楼,成立日期1995年1月 ...
合煦智远消费主题股票发起式A:2025年第一季度利润1.99万元 净值增长率1.47%
Sou Hu Cai Jing· 2025-05-06 11:53
Core Viewpoint - The AI Fund He Xu Zhi Yuan Consumer Theme Stock Initiation A (007287) reported a profit of 19,900 yuan in Q1 2025, with a net asset value growth rate of 1.47% during the period [3][16]. Fund Performance - As of April 24, the fund's unit net value was 1.119 yuan, with a three-month net value growth rate of 3.74%, ranking 31 out of 46 comparable funds [4][3]. - Over the past year, the fund's net value growth rate was 0.18%, ranking 20 out of 46, while the three-year growth rate was 7.59%, ranking 6 out of 43 [4][3]. Fund Management Strategy - The fund manager, Yang Zhiyong, indicated a strategy focused on aggressive investment in the consumer sector, while also participating in industrial machinery and integrated circuits [3]. - The fund's average stock position over the past three years was 66.86%, compared to the industry average of 87.29% [15]. Risk Metrics - The fund's Sharpe ratio over the past three years was 0.4152, ranking 7 out of 42 comparable funds [10]. - The maximum drawdown over the past three years was 22.19%, with the largest single-quarter drawdown occurring in Q1 2022 at 24.08% [12]. Fund Holdings - As of Q1 2025, the top ten holdings of the fund included BYD, Luzhou Laojiao, Shanxi Fenjiu, Wens Foodstuff Group, Seres, Midea Group, China Duty Free Group, Wuliangye, Sanhua Intelligent Control, and Kweichow Moutai [19].